Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marilyn A. Metcalf"'
Autor:
Khaled Alamri, Molly L. Aldridge, Larry Alphs, Barbara E. Bierer, Eric P. Borrelli, Jaclyn L.F. Bosco, Nicholas Brooke, Emily S. Brouwer, Aisling R. Caffrey, Alicyn Campbell, Timothy S. Carey, Wendy Camelo Castillo, John Chaplin, Jennifer B. Christian, Thomas W. Concannon, Catherine Copley-Merriman, Kourtney Davis, Robert S. Epstein, Nicolle M. Gatto, Cynthia J. Girman, Rolf H.H. Groenwold, Cynthia Grossman, Kristen A. Hahn, Anne Marie Hamior, Katherine E. Harris, Ehab Hasan, Austin R. Horn, Phyo T. Htoo, Kristy Iglay, Michele Jonsson Funk, Sylvia Baedorf Kassis, Bray Patrick Lake, Suzanne N. Landi, Craig Lipset, Vincent Lo Re, Jennifer L. Lund, Kenneth Man, Elizabeth Manning, Leah McGrath, Michelle Medeiros, Marilyn A. Metcalf, Margaret Mordin, Mary Stober Murray, Nabil Natafgi, Catherine A. Panozzo, Jeanne M. Pimenta, Sudha R. Raman, Jeanne M. Regnante, Nicole A. Richie, Mary E. Ritchey, Jamie Roberts, Ify Sargeant, Roslyn F. Schneider, Suzanne Schrandt, Joe V. Selby, Soko Setoguchi, Ju-Young (Judy) Shin, Joanna Siegel, Fabian Somers, Komathi Stem, Til Stürmer, Elizabeth A. Suarez, J. Russell Teagarden, Kevin E. Thorpe, Lina Titievsky, Andrea B. Troxel, Priscilla Velentgas, Cunlin Wang, Jenna Wong, Stephen Yates, Guy Yeoman, Wei Zhou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfe115e0e1fb3d212f5d186895ac3cf3
https://doi.org/10.1016/b978-0-12-817663-4.01002-3
https://doi.org/10.1016/b978-0-12-817663-4.01002-3
Autor:
Bray Patrick Lake, Nicholas Brooke, Jamie Roberts, Cynthia Grossman, Anne Marie Hamior, Elizabeth Manning, Roslyn F. Schneider, Fabian Somers, Nicole Richie, Stephen Yates, Alicyn Campbell, Sylvia Baedorf Kassis, Jeanne M. Regnante, Barbara E. Bierer, Guy Yeoman, Suzanne Schrandt, Ify Sargeant, Mary Stober Murray, Marilyn A. Metcalf, Craig Lipset
In this Chapter, Patient Voice in Clinical Trial Programs in Industry, we argue that the Life Sciences industry must adapt if they are to succeed and make medicines with (rather than just for) patients. Those companies able to deliver medicines and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e570bffeaf1266249cced0186aa21eb
https://doi.org/10.1016/b978-0-12-817663-4.00026-x
https://doi.org/10.1016/b978-0-12-817663-4.00026-x
Autor:
Diana, Hughes, Ed, Waddingham, Shahrul, Mt-Isa, Alesia, Goginsky, Edmond, Chan, Gerald F, Downey, Christine E, Hallgreen, Kimberley S, Hockley, Juhaeri, Juhaeri, Alfons, Lieftucht, Marilyn A, Metcalf, Rebecca A, Noel, Lawrence D, Phillips, Deborah, Ashby, Alain, Micaleff
Publikováno v:
Pharmacoepidemiology and drug safety. 25(3)
The purpose of this study is to draw on the practical experience from the PROTECT BR case studies and make recommendations regarding the application of a number of methodologies and visual representations for benefit-risk assessment.Eight case studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e28494c1fe9ac4f2c197f258154afc50
https://pubmed.ncbi.nlm.nih.gov/26800458
https://pubmed.ncbi.nlm.nih.gov/26800458
